Loading…

Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone

Purpose: 5-Aminolevulinic acid (ALA) is a precursor of the photosensitizer protoporphyrin (PpIX) used in photodynamic therapy. In our previous work, PpIX enhanced the generation of reactive oxygen species by X-ray irradiation. In this study, we evaluated the potential of ALA as an endogenous sensiti...

Full description

Saved in:
Bibliographic Details
Published in:International journal of radiation biology 2016-12, Vol.92 (12), p.774-789
Main Authors: Takahashi, Junko, Misawa, Masaki, Iwahashi, Hitoshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-607a20cf62bc38099d627e061a862d9da3a938972c069521f7f9fbeb3cacfc953
cites cdi_FETCH-LOGICAL-c366t-607a20cf62bc38099d627e061a862d9da3a938972c069521f7f9fbeb3cacfc953
container_end_page 789
container_issue 12
container_start_page 774
container_title International journal of radiation biology
container_volume 92
creator Takahashi, Junko
Misawa, Masaki
Iwahashi, Hitoshi
description Purpose: 5-Aminolevulinic acid (ALA) is a precursor of the photosensitizer protoporphyrin (PpIX) used in photodynamic therapy. In our previous work, PpIX enhanced the generation of reactive oxygen species by X-ray irradiation. In this study, we evaluated the potential of ALA as an endogenous sensitizer to X-ray irradiation. Methodology: Tumor-bearing C57BL/6J mice implanted with B16-BL6 melanoma cells were subsequently treated with irradiation (3 Gy/day for 10 days; total, 30 Gy) plus local administration of 50 mg/kg ALA 24 hours prior to each irradiation (ALA-XT). Tumor-bearing mice without treatment (NT), those treated with ALA only (ALAT), and those treated with X-ray irradiation only (XT) were used as controls. Results: ALA potentiated tumor suppression by X-ray irradiation. In microarray analyses using tumor tissue collected after 10 sessions of fractional irradiation, functional analysis revealed that the majority of dysregulated genes in the XT and ALA-XT groups were related to cell-cycle arrest. Finally, the XT and ALA-XT groups differed in the strength of expression, but not in the pattern of expression. Conclusions: mRNA analysis revealed that the combined use of ALA and X-ray irradiation sensitized tumors to X-ray treatment. Furthermore, the present results were consistent with ALA's tumor suppressive effects in vivo.
doi_str_mv 10.1080/09553002.2016.1230240
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_27586078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835388804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-607a20cf62bc38099d627e061a862d9da3a938972c069521f7f9fbeb3cacfc953</originalsourceid><addsrcrecordid>eNp9kc-OFCEQh4nRuOOuj6Dh6KVHGrZpuGkm_ks28bImeyPVdJHF0DAC42YeaN9TOjPryXiiEr6qH9RHyJuebXum2Humh0Ewxrec9XLbc8H4NXtGNr2QvBPt9jnZrEy3QhfkVSk_WauYUC_JBR8HJdmoNuRxl5bJR5xpzQh1wVjpg6_39K7LcKQ-Z5g9VJ8ihTjToYPFxxTw9yH46C0F62eKwVtfC52wVsxtEsRis9_XtDQkY9mnWJAmRy2GQO3RBuwyBqgt14GtKRda7yH-KzWkiFfkhYNQ8PX5vCQ_Pn-63X3tbr5_-bb7eNNZIWXt2peAM-skn6xQTOtZ8hGZ7EFJPusZBGih9Mgtk3rgvRuddhNOwoJ1Vg_ikrw7zd3n9OuApZrFl_XNEDEdiumVGIRSil03dDihNqdSMjqzz36BfDQ9M6sh82TIrIbM2VDre3uOOEwLzn-7npQ04MMJ8NGlvMBDymE2FY4hZdc2a30x4v8ZfwAQPqN5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835388804</pqid></control><display><type>article</type><title>Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Takahashi, Junko ; Misawa, Masaki ; Iwahashi, Hitoshi</creator><creatorcontrib>Takahashi, Junko ; Misawa, Masaki ; Iwahashi, Hitoshi</creatorcontrib><description>Purpose: 5-Aminolevulinic acid (ALA) is a precursor of the photosensitizer protoporphyrin (PpIX) used in photodynamic therapy. In our previous work, PpIX enhanced the generation of reactive oxygen species by X-ray irradiation. In this study, we evaluated the potential of ALA as an endogenous sensitizer to X-ray irradiation. Methodology: Tumor-bearing C57BL/6J mice implanted with B16-BL6 melanoma cells were subsequently treated with irradiation (3 Gy/day for 10 days; total, 30 Gy) plus local administration of 50 mg/kg ALA 24 hours prior to each irradiation (ALA-XT). Tumor-bearing mice without treatment (NT), those treated with ALA only (ALAT), and those treated with X-ray irradiation only (XT) were used as controls. Results: ALA potentiated tumor suppression by X-ray irradiation. In microarray analyses using tumor tissue collected after 10 sessions of fractional irradiation, functional analysis revealed that the majority of dysregulated genes in the XT and ALA-XT groups were related to cell-cycle arrest. Finally, the XT and ALA-XT groups differed in the strength of expression, but not in the pattern of expression. Conclusions: mRNA analysis revealed that the combined use of ALA and X-ray irradiation sensitized tumors to X-ray treatment. Furthermore, the present results were consistent with ALA's tumor suppressive effects in vivo.</description><identifier>ISSN: 0955-3002</identifier><identifier>EISSN: 1362-3095</identifier><identifier>DOI: 10.1080/09553002.2016.1230240</identifier><identifier>PMID: 27586078</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>5-aminolevulinic acid (ALA) ; Aminolevulinic Acid - administration &amp; dosage ; Animals ; Apoptosis - drug effects ; Apoptosis - radiation effects ; Cell Cycle - drug effects ; Cell Cycle - radiation effects ; Cell Cycle Proteins - metabolism ; Cell Line, Tumor ; Female ; Gene Expression Regulation, Neoplastic - drug effects ; Gene Expression Regulation, Neoplastic - radiation effects ; Mice ; Mice, Inbred C57BL ; mouse caner model ; Neoplasms, Experimental - drug therapy ; Neoplasms, Experimental - metabolism ; Neoplasms, Experimental - pathology ; Photochemotherapy - methods ; protpporphyrin IX (PpIX) ; Radiation Tolerance - drug effects ; Radiation Tolerance - radiation effects ; Radiation-Sensitizing Agents - administration &amp; dosage ; Radiotherapy ; sensitizer ; Space life sciences ; Transcriptome - radiation effects ; X-ray ; X-Rays</subject><ispartof>International journal of radiation biology, 2016-12, Vol.92 (12), p.774-789</ispartof><rights>2016 Informa UK Limited, trading as Taylor &amp; Francis Group 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-607a20cf62bc38099d627e061a862d9da3a938972c069521f7f9fbeb3cacfc953</citedby><cites>FETCH-LOGICAL-c366t-607a20cf62bc38099d627e061a862d9da3a938972c069521f7f9fbeb3cacfc953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27586078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takahashi, Junko</creatorcontrib><creatorcontrib>Misawa, Masaki</creatorcontrib><creatorcontrib>Iwahashi, Hitoshi</creatorcontrib><title>Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone</title><title>International journal of radiation biology</title><addtitle>Int J Radiat Biol</addtitle><description>Purpose: 5-Aminolevulinic acid (ALA) is a precursor of the photosensitizer protoporphyrin (PpIX) used in photodynamic therapy. In our previous work, PpIX enhanced the generation of reactive oxygen species by X-ray irradiation. In this study, we evaluated the potential of ALA as an endogenous sensitizer to X-ray irradiation. Methodology: Tumor-bearing C57BL/6J mice implanted with B16-BL6 melanoma cells were subsequently treated with irradiation (3 Gy/day for 10 days; total, 30 Gy) plus local administration of 50 mg/kg ALA 24 hours prior to each irradiation (ALA-XT). Tumor-bearing mice without treatment (NT), those treated with ALA only (ALAT), and those treated with X-ray irradiation only (XT) were used as controls. Results: ALA potentiated tumor suppression by X-ray irradiation. In microarray analyses using tumor tissue collected after 10 sessions of fractional irradiation, functional analysis revealed that the majority of dysregulated genes in the XT and ALA-XT groups were related to cell-cycle arrest. Finally, the XT and ALA-XT groups differed in the strength of expression, but not in the pattern of expression. Conclusions: mRNA analysis revealed that the combined use of ALA and X-ray irradiation sensitized tumors to X-ray treatment. Furthermore, the present results were consistent with ALA's tumor suppressive effects in vivo.</description><subject>5-aminolevulinic acid (ALA)</subject><subject>Aminolevulinic Acid - administration &amp; dosage</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - radiation effects</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Cycle - radiation effects</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Gene Expression Regulation, Neoplastic - radiation effects</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>mouse caner model</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Neoplasms, Experimental - metabolism</subject><subject>Neoplasms, Experimental - pathology</subject><subject>Photochemotherapy - methods</subject><subject>protpporphyrin IX (PpIX)</subject><subject>Radiation Tolerance - drug effects</subject><subject>Radiation Tolerance - radiation effects</subject><subject>Radiation-Sensitizing Agents - administration &amp; dosage</subject><subject>Radiotherapy</subject><subject>sensitizer</subject><subject>Space life sciences</subject><subject>Transcriptome - radiation effects</subject><subject>X-ray</subject><subject>X-Rays</subject><issn>0955-3002</issn><issn>1362-3095</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kc-OFCEQh4nRuOOuj6Dh6KVHGrZpuGkm_ks28bImeyPVdJHF0DAC42YeaN9TOjPryXiiEr6qH9RHyJuebXum2Humh0Ewxrec9XLbc8H4NXtGNr2QvBPt9jnZrEy3QhfkVSk_WauYUC_JBR8HJdmoNuRxl5bJR5xpzQh1wVjpg6_39K7LcKQ-Z5g9VJ8ihTjToYPFxxTw9yH46C0F62eKwVtfC52wVsxtEsRis9_XtDQkY9mnWJAmRy2GQO3RBuwyBqgt14GtKRda7yH-KzWkiFfkhYNQ8PX5vCQ_Pn-63X3tbr5_-bb7eNNZIWXt2peAM-skn6xQTOtZ8hGZ7EFJPusZBGih9Mgtk3rgvRuddhNOwoJ1Vg_ikrw7zd3n9OuApZrFl_XNEDEdiumVGIRSil03dDihNqdSMjqzz36BfDQ9M6sh82TIrIbM2VDre3uOOEwLzn-7npQ04MMJ8NGlvMBDymE2FY4hZdc2a30x4v8ZfwAQPqN5</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Takahashi, Junko</creator><creator>Misawa, Masaki</creator><creator>Iwahashi, Hitoshi</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20161201</creationdate><title>Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone</title><author>Takahashi, Junko ; Misawa, Masaki ; Iwahashi, Hitoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-607a20cf62bc38099d627e061a862d9da3a938972c069521f7f9fbeb3cacfc953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>5-aminolevulinic acid (ALA)</topic><topic>Aminolevulinic Acid - administration &amp; dosage</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - radiation effects</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Cycle - radiation effects</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Gene Expression Regulation, Neoplastic - radiation effects</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>mouse caner model</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Neoplasms, Experimental - metabolism</topic><topic>Neoplasms, Experimental - pathology</topic><topic>Photochemotherapy - methods</topic><topic>protpporphyrin IX (PpIX)</topic><topic>Radiation Tolerance - drug effects</topic><topic>Radiation Tolerance - radiation effects</topic><topic>Radiation-Sensitizing Agents - administration &amp; dosage</topic><topic>Radiotherapy</topic><topic>sensitizer</topic><topic>Space life sciences</topic><topic>Transcriptome - radiation effects</topic><topic>X-ray</topic><topic>X-Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takahashi, Junko</creatorcontrib><creatorcontrib>Misawa, Masaki</creatorcontrib><creatorcontrib>Iwahashi, Hitoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of radiation biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takahashi, Junko</au><au>Misawa, Masaki</au><au>Iwahashi, Hitoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone</atitle><jtitle>International journal of radiation biology</jtitle><addtitle>Int J Radiat Biol</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>92</volume><issue>12</issue><spage>774</spage><epage>789</epage><pages>774-789</pages><issn>0955-3002</issn><eissn>1362-3095</eissn><abstract>Purpose: 5-Aminolevulinic acid (ALA) is a precursor of the photosensitizer protoporphyrin (PpIX) used in photodynamic therapy. In our previous work, PpIX enhanced the generation of reactive oxygen species by X-ray irradiation. In this study, we evaluated the potential of ALA as an endogenous sensitizer to X-ray irradiation. Methodology: Tumor-bearing C57BL/6J mice implanted with B16-BL6 melanoma cells were subsequently treated with irradiation (3 Gy/day for 10 days; total, 30 Gy) plus local administration of 50 mg/kg ALA 24 hours prior to each irradiation (ALA-XT). Tumor-bearing mice without treatment (NT), those treated with ALA only (ALAT), and those treated with X-ray irradiation only (XT) were used as controls. Results: ALA potentiated tumor suppression by X-ray irradiation. In microarray analyses using tumor tissue collected after 10 sessions of fractional irradiation, functional analysis revealed that the majority of dysregulated genes in the XT and ALA-XT groups were related to cell-cycle arrest. Finally, the XT and ALA-XT groups differed in the strength of expression, but not in the pattern of expression. Conclusions: mRNA analysis revealed that the combined use of ALA and X-ray irradiation sensitized tumors to X-ray treatment. Furthermore, the present results were consistent with ALA's tumor suppressive effects in vivo.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>27586078</pmid><doi>10.1080/09553002.2016.1230240</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0955-3002
ispartof International journal of radiation biology, 2016-12, Vol.92 (12), p.774-789
issn 0955-3002
1362-3095
language eng
recordid cdi_pubmed_primary_27586078
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects 5-aminolevulinic acid (ALA)
Aminolevulinic Acid - administration & dosage
Animals
Apoptosis - drug effects
Apoptosis - radiation effects
Cell Cycle - drug effects
Cell Cycle - radiation effects
Cell Cycle Proteins - metabolism
Cell Line, Tumor
Female
Gene Expression Regulation, Neoplastic - drug effects
Gene Expression Regulation, Neoplastic - radiation effects
Mice
Mice, Inbred C57BL
mouse caner model
Neoplasms, Experimental - drug therapy
Neoplasms, Experimental - metabolism
Neoplasms, Experimental - pathology
Photochemotherapy - methods
protpporphyrin IX (PpIX)
Radiation Tolerance - drug effects
Radiation Tolerance - radiation effects
Radiation-Sensitizing Agents - administration & dosage
Radiotherapy
sensitizer
Space life sciences
Transcriptome - radiation effects
X-ray
X-Rays
title Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T03%3A12%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20treatment%20with%20X-ray%20irradiation%20and%205-aminolevulinic%20acid%20elicits%20better%20transcriptomic%20response%20of%20cell%20cycle-related%20factors%20than%20X-ray%20irradiation%20alone&rft.jtitle=International%20journal%20of%20radiation%20biology&rft.au=Takahashi,%20Junko&rft.date=2016-12-01&rft.volume=92&rft.issue=12&rft.spage=774&rft.epage=789&rft.pages=774-789&rft.issn=0955-3002&rft.eissn=1362-3095&rft_id=info:doi/10.1080/09553002.2016.1230240&rft_dat=%3Cproquest_pubme%3E1835388804%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-607a20cf62bc38099d627e061a862d9da3a938972c069521f7f9fbeb3cacfc953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835388804&rft_id=info:pmid/27586078&rfr_iscdi=true